Sacral nerve stimulation involves mild electrical stimulation of the sacral nerves that controls bladder and bowel function. It is a treatment option for patients with urinary or fecal incontinence. The device used for sacral nerve stimulation includes implantable leads, an implantable pulse generator, and an external programmer. Patients with urinary urge incontinence benefit the most from sacral nerve stimulation. The global sacral nerve stimulation market is driven by the growing geriatric population and rising prevalence of urinary incontinence issues. Rapid advancements in healthcare infrastructure and rising medical expenditures also support the growth of this market.
The global sacral nerve stimulation Market is estimated to be valued at US$ 444.7 in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
One of the key drivers fueling the growth of the global sacral nerve stimulation market is rapid advancements in healthcare infrastructure. There has been considerable investments in developing better healthcare facilities and improving access to advanced medical treatments in major markets globally. This has made sacral nerve stimulation therapy more widely available for the treatment of urinary and fecal incontinence. Furthermore, favorable reimbursement policies for urinary incontinence procedures in developed regions is also boosting the adoption of sacral nerve stimulation. Technological advancements in sacral nerve stimulation devices with improvements in terms of effectiveness, comfort, and longevity have boosted overall market growth over the forecast period.
The global sacral nerve stimulation market is dominated by the overactive bladder sub segment. Overactive bladder accounts for approximately 65% of the overall market share owing to the growing geriatric population worldwide who are more prone to conditions like urinary incontinence which lead to overactive bladder. Most sacral nerve stimulation devices available are targeted at treating overactive bladder symptoms and conditions.
Political: The growth of the market is influenced by regulations and reimbursement policies set by governing healthcare bodies. Favorable reimbursement policies by insurance providers boost the adoption of sacral nerve stimulation devices.
Economic: Rising healthcare expenditures, growing economies, and increasing disposable incomes support the growth of this market. The availability of affordable devices also propels the market forward.
Social: An aging global population drives the need for effective treatment options. Awareness about conditions like overactive bladder is rising and reducing the social stigma around incontinence issues.
Technological: Advancements in materials, miniaturization, and battery technology aid in developing innovative sacral nerve stimulation devices. Bluetooth and wifi enabled devices allow for remote programming and monitoring.
The Global Sacral Nerve Stimulation Market Demand is expected to witness high growth over the forecast period driven by a growing elderly population worldwide that is more prone to conditions like overactive bladder that require sacral nerve stimulation treatment.
Regional analysis: The Asia Pacific region is anticipated to show lucrative growth opportunities for the sacral nerve stimulation market over the forecast period. Countries like China, India, Japan, and South Korea have a large aging demographic that are more susceptible to overactive bladder issues. Additionally, growing medical tourism, rapid economic development, and healthcare infrastructure expansion in the region also support market growth. Manufacturers are focusing on expanding their presence in Asia Pacific through partnerships and launched of affordable devices tailored for the regional requirements.
Key players operating in the sacral nerve stimulation market are Medtronic plc, Boston Scientific Corporation, Nevro Corp, StimWave Technologies Inc., Axonics, Inc, Synapse Biomedical, Uroplasty. Medtronic plc dominates the global market with its InterStim device offerings for sacral nerve stimulation therapy. Boston Scientific also has a strong product portfolio with the Enterra and Butee devices.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it